Social Cognitive Assessment in Autism and Schizophrenia
(ClaCoS)
1 other identifier
interventional
440
1 country
1
Brief Summary
In people with schizophrenia or people with autism, impairments of social cognition are a core feature of the disease and, according to researchers who represent valuable references on this subject for the international community, three to five processes of social cognition are usually altered in those diseases: (1) emotional processing which is the ability to identify emotions through facial expressions, gestures, and tone of voice, (2) theory of mind (ToM), which is defined as "the ability to attribute mental states (beliefs, intents, desires, …) to oneself and others, and to understand that others have beliefs, intentions, and desires that are different from one's own", (3) attributional style which refers to how people explain the causes of positive and negative events, and corresponding, in schizophrenia, to self-serving and personalizing bias that means a tendency to blame others for negative life events rather than sharing the responsibilities between different sources; and (4 and 5) social perception and knowledge, which can be defined as decoding and interpreting social cues from others, taking the social context into account, and knowing social rules, roles, and goals. Components of social cognition appear to be related to both symptomatology and functioning in everyday life. The present study aims to assess a new social cognitive battery developed by several teams in France: ClaCoS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Dec 2015
Longer than P75 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 4, 2015
CompletedFirst Submitted
Initial submission to the registry
December 16, 2015
CompletedFirst Posted
Study publicly available on registry
January 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJanuary 27, 2022
January 1, 2022
5.3 years
December 16, 2015
January 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in social cognition measures
The battery (ClaCoS ) is composed by 6 tests and several scores will be recorded for each: * for emotion perception : total score, score per emotion, detection levels (TREF) * for theory of mind : total score, error type (MASC) * for attributional bias : hostility score, attribution score, aggression score (AIHQ ) * for social perception and knowledge : interpretation score - with and without index, comprehension score (PerSo) * for empathy : Empathy quotient (EQ) for people with autism / Questionnaire of cognitive and affective empathy (QCAE )for people with schizophrenia (total score and sub scores) * for self assessment : total score and scores per processes( ACSo )
Week 12
Secondary Outcomes (2)
Change from Baseline in symptoms measure
Week 12
Change from Baseline in Neurocognitive functioning measures
Week 12
Study Arms (3)
schizophrenia
EXPERIMENTALthis project is to assess relevance of ClaCoS in schizophrenia compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.
autism
EXPERIMENTALthis project is to assess relevance of ClaCoS in autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.
healthy controls
PLACEBO COMPARATORthis project is to assess relevance of ClaCoS in autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.
Interventions
The battery (ClaCoS) is composed by 6 tests and several scores will be recorded for each: * for emotion perception : Facial emotions recognition task (TREF) * for theory of mind : Movie for the assessment of social cognition ( MASC-VF) * for attributional bias : Ambiguous Intentions Hostility Questionnaire ( AIHQ) * for social perception and knowledge : interpretation score - with and without index, comprehension score ( PerSo ) * for empathy :Questionnaire of cognitive and affective empathy ( QCAE) for people with schizophrenia * for self assessment : Self - assessment of social cognition (ACSo)
The battery (ClaCoS ) is composed by 6 tests and several scores will be recorded for each: * for emotion perception : Facial emotions recognition task(TREF ): total score, score per emotion, detection levels * for theory of mind : Movie for the assessment of social cognition (MASC ) :total score, error type * for attributional bias : Ambiguous Intentions Hostility Questionnaire (AIHQ) :hostility score, attribution score, aggression score * for social perception and knowledge : interpretation score - with and without index, comprehension score ( PerSo ) * for empathy : Empathy quotient (EQ) * for self assessment : Self - assessment of social cognition ( ACSo ): total score and scores per processes
Eligibility Criteria
You may qualify if:
- Aged 18-45 years old
- No psychiatric or neurologic conditions or comorbidity
- No relatives with people with people with history of neuropsychiatric disease
- French native language or education in a French school since the first year of primary school
- Consent to participate to the study
You may not qualify if:
- Aged 18-45 years old
- Patients with schizophrenia: diagnosis assessed with DSM5 criteria
- French native language or education in a French school since the first year of primary school
- Consent to participate to the study and agreement of the legal guardian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Professeur FRANCK Nicolas
Bron, Auvergne-Rhône-Alpes, 69678, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
FRANCK NICOLAS, PUPH
Service Universitaire de Réhabilitation - Le Vinatier Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2015
First Posted
January 21, 2016
Study Start
December 4, 2015
Primary Completion
March 31, 2021
Study Completion
June 30, 2021
Last Updated
January 27, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share